New Schedule M Requirements Pose Challenge for Drug Manufacturers

According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.

NPPA Caps Prices of 84 Drug Combinations, Including Empagliflozin Variants

The National Pharmaceutical Pricing Authority (NPPA) has set 84 drug formulations' retail prices, including 36 formulations of empagliflozin, a diabetes drug that was originally developed by German firm Boehringer Ingelheim...

FDCA Gujarat Acts Against Illegal Psychotropic Drug Sales

A significant attempt to stop illegal sale of narcotic and psychotropic drugs has been made by the Gujarat Food and Drugs Control Administration (FDCA) in a major crackdown effort on the illicit sale of drugs in the state...

Corporate brand campaign launched in India by Sun Pharma

Sun Pharmaceutical Industries Limited (Sun Pharma), India's largest pharmaceutical company, has initiated a brand campaign that celebrates its contribution to the lives of people. Called 'touching 1,000...

Pharma Quality Excellence Awards 2025 - Celebration and Conclusion

The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to pharmaceutical quality standards. Held in Hotel Westin Mumbai Garden City, it brought together industry leaders, quality pro

Pharma Science Revives Ayurveda with Zero Investment Plan

Pharma Science, a leader in India's Ayurvedic healthcare industry, is revolutionizing natural wellness with clinically proven, patented products and an open business model...

Venus Remedies Taps Ekta S. Chaudhary to Lead Venus Foundation

Venus Remedies has declared the appointment of Ekta S. Chaudhary as the new Chairperson of the Venus Foundation, marking a major step in the company’s commitment to social responsibility.

ProBioGen & Polpharma Biologics team up for biosimilar cell lines

Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...

Indian Drugmakers Face Heat as FDA Expands Surprise Global Inspections

In an effort to improve consumer safety and reinforce regulatory compliance, the US Food and Drug Administration (FDA) announced on Tuesday that it will raise the frequency of surprise inspections at foreign manufacturing facilities.

DTAB Recommends All Antimicrobials Be Treated as New Drugs to Tackle AMR

In a major regulatory move aimed at curbing antimicrobial resistance (AMR), the Drugs Technical Advisory Board (DTAB) has recommended that all antimicrobials should be permanently classified as...

© 2025 India Pharma Outlook. All Rights Reserved.